NovaBridge Biosciences NBP
NASDAQ NBP
$1.38 +0.00 (+0.36%)
As of: Sep 30, 2026 · 11:48 AM EDT

NovaBridge Biosciences (NBP) Receivables - Accured (2018 - 2026)

Updated

NovaBridge Biosciences (NBP) reported Receivables - Accured of $2,000 for Q2 2026, down 92.9% from $28,000 a year earlier.

Analysis

NovaBridge Biosciences (NBP) Receivables - Accured (2018 - 2026) Analysis & Trends

At the end of FY2025, NovaBridge Biosciences posted Receivables - Accured of $5,000, down 99.5% from FY2024.

  • Receivables - Accured has a five-year compound annual growth rate of -32.6% (FY2020 to FY2025).
  • By year, Receivables - Accured came in at $1.04 million in FY2024.
  • The Q2 2026 figure ranks as the lowest quarterly Receivables - Accured in data going back to Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables - Accured (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 NovaBridge Biosciences 149.78 Mn 149.78 Mn - 2,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,000.00
Dec 31, 2025 5,000.00
Sep 30, 2025 30,000.00
Jun 30, 2025 28,000.00
Dec 31, 2024 1.04 Mn
Dec 31, 2020 35,610.82
Dec 31, 2019 108,396.91
Dec 31, 2018 217,233.64
API Access

NovaBridge Biosciences Receivables - Accured API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-accured&ticker=NBP&period=max&api_key=YOUR_API_KEY